Tenaya Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -1.2% | -1.5% | -1.0% | -0.6% | +27.4% | -10.4% | -21.8% | -3.6% | -1.8% | +96.3% | – | |
| – | -1.6% | +7.0% | +9.2% | -15.3% | -3.8% | -0.7% | -2.5% | -19.3% | -6.4% | -20.0% | +77.5% | – | |
| – | – | – | – | – | – | – | – | -191.5% | – | -613.2% | – | – | |
| – | +4,825.0% | +43.1% | -87.1% | +152.1% | +10.9% | +87.7% | -62.9% | -81.7% | +157.7% | -83.6% | +1,445.5% | – | |
| – | -148.9% | -69.9% | – | -239.2% | – | +58.1% | +12.0% | -64.5% | -100.8% | -83.6% | +1,445.5% | – | |
| – | – | +12,506.7% | -98.8% | -94.6% | +1,116.1% | +13,231.3% | -100.9% | – | +15,226.8% | -100.7% | – | – | |
| – | -632.4% | – | -110.5% | – | – | – | -82.0% | -171.5% | – | -144.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.